NO301475B1 - Analogifremgangsmåte ved fremstilling av terapeutisk aktive sertindolderivater - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive sertindolderivater

Info

Publication number
NO301475B1
NO301475B1 NO931219A NO931219A NO301475B1 NO 301475 B1 NO301475 B1 NO 301475B1 NO 931219 A NO931219 A NO 931219A NO 931219 A NO931219 A NO 931219A NO 301475 B1 NO301475 B1 NO 301475B1
Authority
NO
Norway
Prior art keywords
sertindole
group
derivatives
preparation
therapeutically active
Prior art date
Application number
NO931219A
Other languages
English (en)
Norwegian (no)
Other versions
NO931219D0 (no
NO931219L (no
Inventor
Jens Kristian Perregaard
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO931219D0 publication Critical patent/NO931219D0/no
Publication of NO931219L publication Critical patent/NO931219L/no
Publication of NO301475B1 publication Critical patent/NO301475B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
NO931219A 1990-10-03 1993-03-31 Analogifremgangsmåte ved fremstilling av terapeutisk aktive sertindolderivater NO301475B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK238190A DK238190D0 (da) 1990-10-03 1990-10-03 Depotderivater
PCT/DK1991/000291 WO1992006089A1 (en) 1990-10-03 1991-09-27 Sertindole prodrugs

Publications (3)

Publication Number Publication Date
NO931219D0 NO931219D0 (no) 1993-03-31
NO931219L NO931219L (no) 1993-04-01
NO301475B1 true NO301475B1 (no) 1997-11-03

Family

ID=8111993

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931219A NO301475B1 (no) 1990-10-03 1993-03-31 Analogifremgangsmåte ved fremstilling av terapeutisk aktive sertindolderivater

Country Status (21)

Country Link
US (1) US5428036A (xx)
EP (1) EP0592433B1 (xx)
JP (1) JP3100980B2 (xx)
KR (1) KR100212430B1 (xx)
AT (1) ATE175964T1 (xx)
AU (1) AU652783B2 (xx)
CA (1) CA2093433C (xx)
DE (1) DE69130803T2 (xx)
DK (2) DK238190D0 (xx)
ES (1) ES2125870T3 (xx)
FI (1) FI102679B1 (xx)
GR (1) GR3029399T3 (xx)
HK (1) HK1009273A1 (xx)
IE (1) IE913384A1 (xx)
IL (1) IL99652A (xx)
NO (1) NO301475B1 (xx)
NZ (1) NZ240051A (xx)
PH (1) PH30129A (xx)
PT (1) PT99142B (xx)
WO (1) WO1992006089A1 (xx)
ZA (1) ZA917881B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
JPH0625964U (ja) * 1992-05-25 1994-04-08 ミクロン機器株式会社 通信機能付きコインカウンタ及び有料装置
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
ES2387562T3 (es) 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
EP1427407A4 (en) * 2001-03-23 2005-05-11 Luitpold Pharm Inc CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
WO2008104942A2 (en) * 2007-02-28 2008-09-04 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
ES2885698T3 (es) 2009-06-25 2021-12-15 Alkermes Pharma Ireland Ltd Profármacos de compuestos nh-ácidos
NZ597107A (en) 2009-06-25 2013-12-20 Alkermes Pharma Ireland Ltd Heterocyclic compounds for the treatment of neurological and psychological disorders
ES2691671T3 (es) * 2010-06-24 2018-11-28 Alkermes Pharma Ireland Limited Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
US4038305A (en) * 1972-03-20 1977-07-26 Aktieselskabet Grindstedvaerket Cyclopentenone derivatives
GB1469108A (en) * 1973-06-25 1977-03-30 Kefalas As Thiaxanthene derivative
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DE3921886A1 (de) * 1989-07-04 1991-01-17 Wolfgang Mohr Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut

Also Published As

Publication number Publication date
FI931472A (fi) 1993-04-01
CA2093433C (en) 2000-11-21
KR100212430B1 (ko) 1999-08-02
FI102679B (fi) 1999-01-29
ES2125870T3 (es) 1999-03-16
HK1009273A1 (en) 1999-05-28
NZ240051A (en) 1993-05-26
IE913384A1 (en) 1992-04-08
AU652783B2 (en) 1994-09-08
AU8710491A (en) 1992-04-28
FI102679B1 (fi) 1999-01-29
KR930702335A (ko) 1993-09-08
ZA917881B (en) 1992-07-29
DK238190D0 (da) 1990-10-03
IL99652A0 (en) 1992-08-18
PT99142A (pt) 1994-02-28
WO1992006089A1 (en) 1992-04-16
NO931219D0 (no) 1993-03-31
NO931219L (no) 1993-04-01
IL99652A (en) 1997-04-15
DE69130803D1 (de) 1999-03-04
DE69130803T2 (de) 1999-08-19
CA2093433A1 (en) 1992-04-04
GR3029399T3 (en) 1999-05-28
DK0592433T3 (da) 1999-09-13
JP3100980B2 (ja) 2000-10-23
PH30129A (en) 1997-01-21
EP0592433B1 (en) 1999-01-20
FI931472A0 (fi) 1993-04-01
ATE175964T1 (de) 1999-02-15
US5428036A (en) 1995-06-27
EP0592433A1 (en) 1994-04-20
PT99142B (pt) 1999-04-30
JPH06501939A (ja) 1994-03-03

Similar Documents

Publication Publication Date Title
NO301475B1 (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive sertindolderivater
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
AT397654B (de) Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
TW238304B (en) A process for the preparation of 1-substituted-5(4H)-tetrazolinones
BG100717A (en) 1,3-oxazin-4-one derivatives, process and intermediates for their preparation and their use
KR880006239A (ko) 기라제 억제제, 그의 제조방법 및 용도
ES8301479A1 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8506015A1 (es) Procedimiento para la preparacion de esteres del acido alcoxivincaminico
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE69327092T2 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
GB949732A (en) New piperidine derivatives and process for their production
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.
HUT53638A (en) Process for producing 15-amino-substituted 20,21-dinoreburnamenie derivatives and pharmaceutical compositions containing them
ES8301482A1 (es) Un procedimiento para la preparacion de un derivado del aci-do clavulanico
GB889660A (en) Morphanthridine compounds
TH13395A (th) อนุพันธ์ของสเทรอยด์สำหรับใช้รักษาอาการต่อมลูกหมากโตเกินไป การเตรียมและการใช้สารนั้น